(Q36492148)

14 August 2017

1 reference

title

Monitoring therapeutic efficacy in breast carcinomas (English)

1 reference

14 August 2017

Anne A Tardivon

1

1 reference

14 August 2017

Liliane Ollivier

series ordinal

2

1 reference

14 August 2017

Carl El Khoury

series ordinal

3

1 reference

14 August 2017

Fabienne Thibault

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

30 May 2006

1 reference

14 August 2017

10

1 reference

inferred from page(s)

published in

European Radiology

1 reference

14 August 2017

16

1 reference

14 August 2017

11

1 reference

14 August 2017

2549-2558

1 reference

https://scigraph.springernature.com/pub.10.1007/s00330-006-0317-z

14 August 2017

0 references

cites work

Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Metastatic breast carcinoma in axillary lymph nodes: in vitro US detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Lymphadenopathy: differentiation of benign from malignant disease--color Doppler US assessment of intranodal angioarchitecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Human breast lesions: characterization with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Axillary lymph nodes: mammographic, pathologic, and clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Accuracy of MRI in the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

MRI of breast cancer: influence of chemotherapy on sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

MR quantification of the washout changes in breast tumors under preoperative chemotherapy: feasibility and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-006-0317-Z

Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging

21 January 2018

1 reference

12 December 2020

Locally advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy

1 reference

12 December 2020

Locally advanced breast carcinoma: computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy (work in progress)

1 reference

12 December 2020

Breast cancer imaging with MRI.

1 reference

12 December 2020

Color Doppler ultrasound as an objective assessment tool for chemotherapeutic response in advanced breast cancer

1 reference

12 December 2020

Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers

1 reference

12 December 2020

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

12 December 2020

Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo1H MR Spectroscopy—A Pilot Study at 4 T

1 reference

12 December 2020

Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy

1 reference

12 December 2020

Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.

1 reference

12 December 2020

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

12 December 2020

FDG-PET and beyond: molecular breast cancer imaging

1 reference

12 December 2020

Imaging of axillary lymph nodes

1 reference

12 December 2020

Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer

1 reference

12 December 2020

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

12 December 2020

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

12 December 2020

Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging

1 reference

12 December 2020

1 reference

12 December 2020

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy

1 reference

12 December 2020

Mammography in the assessment of response to medical treatment of large primary breast cancer

1 reference

12 December 2020

Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging

1 reference

12 December 2020

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer

1 reference

12 December 2020

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer

1 reference

12 December 2020

MR imaging of the breast

1 reference

12 December 2020

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

12 December 2020

Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.

1 reference

12 December 2020

Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy

1 reference

12 December 2020

Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients

1 reference

12 December 2020

Color-doppler using contrast medium in evaluating the response to neoadjuvant treatment in patients with locally advanced breast carcinoma

1 reference

12 December 2020

Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer

1 reference

12 December 2020

18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study

1 reference

12 December 2020

Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI

1 reference

12 December 2020

Macromolecular contrast agents for MR mammography: current status

1 reference

12 December 2020

Clinical, mammographic, and sonographic determination of preoperative breast cancer size

1 reference

12 December 2020

Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases

1 reference

12 December 2020

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy

1 reference

12 December 2020

A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility

1 reference

12 December 2020

Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study

1 reference

12 December 2020

The progress and promise of molecular imaging probes in oncologic drug development

1 reference

12 December 2020

Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition

1 reference

12 December 2020

Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution

1 reference

12 December 2020

Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy

1 reference

12 December 2020

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?

1 reference

12 December 2020

Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.

1 reference

12 December 2020

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.

1 reference

12 December 2020

Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study

1 reference

12 December 2020

10.1007/S00330-006-0317-Z

Identifiers

DOI

1 reference

14 August 2017

1 reference